Literature DB >> 35263574

Induction of broadly reactive influenza antibodies increases susceptibility to autoimmunity.

Jocelyn G Labombarde1, Meenu R Pillai1, Marie Wehenkel1, Chun-Yang Lin2, Rachael Keating1, Scott A Brown1, Jeremy Chase Crawford1, David C Brice1, Ashley H Castellaw1, Alexandra H Mandarano1, Clifford S Guy1, Juan R Mejia1, Carlessia D Lewis1, Ti-Cheng Chang3, Christine M Oshansky1, Sook-San Wong4, Richard J Webby4, Mei Yan5, Quan-Zhen Li5, Tony N Marion6, Paul G Thomas1, Maureen A McGargill7.   

Abstract

Infection and vaccination repeatedly expose individuals to antigens that are conserved between influenza virus subtypes. Nevertheless, antibodies recognizing variable influenza epitopes greatly outnumber antibodies reactive against conserved epitopes. Elucidating factors contributing to the paucity of broadly reactive influenza antibodies remains a major obstacle for developing a universal influenza vaccine. Here, we report that inducing broadly reactive influenza antibodies increases autoreactive antibodies in humans and mice and exacerbates disease in four distinct models of autoimmune disease. Importantly, transferring broadly reactive influenza antibodies augments disease in the presence of inflammation or autoimmune susceptibility. Further, broadly reactive influenza antibodies spontaneously arise in mice with defects in B cell tolerance. Together, these data suggest that self-tolerance mechanisms limit the prevalence of broadly reactive influenza antibodies, which can exacerbate disease in the context of additional risk factors.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antibody; autoimmunity; influenza; universal influenza vaccine

Mesh:

Substances:

Year:  2022        PMID: 35263574      PMCID: PMC9036619          DOI: 10.1016/j.celrep.2022.110482

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.995


  79 in total

1.  Antigen specificity of antihistone antibodies in systemic sclerosis.

Authors:  M Hasegawa; S Sato; K Kikuchi; K Takehara
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

2.  Polyreactivity and autoreactivity among HIV-1 antibodies.

Authors:  Mengfei Liu; Guang Yang; Kevin Wiehe; Nathan I Nicely; Nathan A Vandergrift; Wes Rountree; Mattia Bonsignori; S Munir Alam; Jingyun Gao; Barton F Haynes; Garnett Kelsoe
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

Review 3.  Broadly neutralizing antibodies against influenza virus and prospects for universal therapies.

Authors:  Damian C Ekiert; Ian A Wilson
Journal:  Curr Opin Virol       Date:  2012-03-21       Impact factor: 7.090

4.  Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome.

Authors:  T W Ho; H J Willison; I Nachamkin; C Y Li; J Veitch; H Ung; G R Wang; R C Liu; D R Cornblath; A K Asbury; J W Griffin; G M McKhann
Journal:  Ann Neurol       Date:  1999-02       Impact factor: 10.422

5.  Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.

Authors:  Jeffrey C Kwong; Priya P Vasa; Michael A Campitelli; Steven Hawken; Kumanan Wilson; Laura C Rosella; Therese A Stukel; Natasha S Crowcroft; Allison J McGeer; Lorne Zinman; Shelley L Deeks
Journal:  Lancet Infect Dis       Date:  2013-06-28       Impact factor: 25.071

6.  Immune history profoundly affects broadly protective B cell responses to influenza.

Authors:  Sarah F Andrews; Yunping Huang; Kaval Kaur; Lyubov I Popova; Irvin Y Ho; Noel T Pauli; Carole J Henry Dunand; William M Taylor; Samuel Lim; Min Huang; Xinyan Qu; Jane-Hwei Lee; Marlene Salgado-Ferrer; Florian Krammer; Peter Palese; Jens Wrammert; Rafi Ahmed; Patrick C Wilson
Journal:  Sci Transl Med       Date:  2015-12-02       Impact factor: 17.956

Review 7.  The human antibody response to influenza A virus infection and vaccination.

Authors:  Florian Krammer
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

8.  Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.

Authors:  Ali H Ellebedy; Florian Krammer; Gui-Mei Li; Matthew S Miller; Christopher Chiu; Jens Wrammert; Cathy Y Chang; Carl W Davis; Megan McCausland; Rivka Elbein; Srilatha Edupuganti; Paul Spearman; Sarah F Andrews; Patrick C Wilson; Adolfo García-Sastre; Mark J Mulligan; Aneesh K Mehta; Peter Palese; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

9.  Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem.

Authors:  C A Thomson; Y Wang; L M Jackson; M Olson; W Wang; A Liavonchanka; L Keleta; V Silva; S Diederich; R B Jones; J Gubbay; J Pasick; M Petric; François Jean; V G Allen; E G Brown; J M Rini; J W Schrader
Journal:  Front Immunol       Date:  2012-05-08       Impact factor: 7.561

10.  Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity.

Authors:  Meghan O Altman; Jack R Bennink; Jonathan W Yewdell; Brantley R Herrin
Journal:  Elife       Date:  2015-08-07       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.